Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical history.

IF 3.2 3区医学 Q2 CLINICAL NEUROLOGY

Journal of Neuropathology and Experimental Neurology Pub Date : 2024-07-31 DOI:10.1093/jnen/nlae086

Heather Smith, Jeffrey Jean, Drew Duckett, Erica Vormittag-Nocito, Behtash G Nezami, Lawrence J Jennings, Jared T Ahrendsen, Ximing J Yang, Ditte Primdahl, Kyle Conway, Wen Zhong, Lucas Santana-Santos, Craig Horbinski, Rudolph J Castellani, Madina Sukhanova, Pouya Jamshidi

引用次数: 0

查看原文本刊更多论文

多模式晚期分子检测对未知原发灶转移瘤分类的诊断效用：一例无已知病史的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Neuropathology and Experimental Neurology 医学-病理学

CiteScore

5.40

自引率

6.20%

发文量

118

审稿时长

6-12 weeks

期刊介绍： Journal of Neuropathology & Experimental Neurology is the official journal of the American Association of Neuropathologists, Inc. (AANP). The journal publishes peer-reviewed studies on neuropathology and experimental neuroscience, book reviews, letters, and Association news, covering a broad spectrum of fields in basic neuroscience with an emphasis on human neurological diseases. It is written by and for neuropathologists, neurologists, neurosurgeons, pathologists, psychiatrists, and basic neuroscientists from around the world. Publication has been continuous since 1942.